Ironwood Pharmaceuticals | IRWD - Spese Di Vendita E Di Amministrazione





Spese Di Vendita E Di Amministrazione Cambiamento Data
Acadia Pharmaceuticals USD 148.57M 12.22M 2026-06
Agios Pharmaceuticals USD 38.46M 4.51M 2026-03
Akebia Therapeutics USD 23.53M 3.19M 2025-12
Alnylam Pharmaceuticals USD 342M 5.92M 2026-09
Amarin USD 18.97M 1.03M 2025-12
Ardelyx USD 101.44M 827K 2026-06
Astellas Pharma JPY 215.07B 19.63B 2026-06
AstraZeneca USD 4.07B 1.73B 2026-09
Charles River Laboratories USD 228.9M 69.47M 2026-06
Coherus Biosciences USD 15M 6.26M 2025-12
Emergent BioSolutions USD 182.8M 82.3M 2023-06
Halozyme Therapeutics USD 57M 10.71M 2026-06
Incyte USD 364.27M 12.54M 2026-09
Ironwood Pharmaceuticals USD 33.33M 2.78M 2024-12
Karyopharm Therapeutics USD 10.42M 861K 2026-03
Lexicon Pharmaceuticals USD 3.98M 195K 2025-12
MacroGenics USD 7.9M 1.81M 2026-06
Moderna USD 216M 43M 2026-06
Myriad Genetics USD 122.3M 6.7M 2025-12
Pacira USD 91.81M 7.93M 2026-06
PTC Therapeutics USD 80.63M 6.74M 2026-06
Puma Biotechnology USD 16.82M 8.15M 2024-09
Sarepta Therapeutics USD 107.6M 53.57M 2026-06
Takeda JPY 271.71B 14.8B 2026-09
Ultragenyx Pharmaceutical USD 88M 1000K 2026-03
Vanda Pharmaceuticals USD 39.28M 1.71M 2024-12